Ethics?


Anonymous

Guest
MiMedx: Not What The Doctor Ordered
Mar. 21, 2014 11:30 AM ET | About: MiMedx Group Inc. (MDXG)
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. (More...)
Summary

Company hands out over 1 million shares of stock and options worth over $7 million to doctor consultants and medical advisory board members.
Practices raise ethical questions, risk of federal violations that have damaged other companies.
Company market cap of about $740 million greatly exceeds estimated $500 million “skin substitution” market.
Doctors, insiders, employees hold options/warrants on over 16 million shares of stock at 90 cents to $2.46.
Analyst slaps MiMedx with lack-luster “market perform” and notes looming uncertainties, issues.
Human placenta products peddler MiMedx (MDXG) is handing out company stock like candy to doctors who "evaluate technologies" or act as consultants, TheStreetSweeper has learned.

One doctor got tens of thousands of shares of common stock without paying one single dime. Another prominent doctor on the company's medical advisory board received options on 200,000 shares.

The company has doled out roughly 1.2 million shares of stock and options to its influential doctor friends - shares now worth more than $7 million - as its chief executive, Parker Petit, prepares to go on trial perhaps as early as next month for an alleged insider trading scheme.

Despite that, the company's stock price is screaming, shoving the market cap into the stratosphere. The company is now valued at about $740 million, much higher than the entire "skin substitution" market estimated at $500 million.

Paid to do what?

MiMedx uses doctors in speaking bureaus, consulting and research. But filings also say doctors educate others about "the efficacy and uses of our products." MiMedx's business turns mothers' placental membranes into "EpiFix" material used to cover injuries such as burns and diabetic foot sores, as well as "AmnioFix" for internal coverage uses such as spinal surgery and tennis elbow.
 

MiMedx: Not What The Doctor Ordered
Mar. 21, 2014 11:30 AM ET | About: MiMedx Group Inc. (MDXG)
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. (More...)
Summary

Company hands out over 1 million shares of stock and options worth over $7 million to doctor consultants and medical advisory board members.
Practices raise ethical questions, risk of federal violations that have damaged other companies.
Company market cap of about $740 million greatly exceeds estimated $500 million “skin substitution” market.
Doctors, insiders, employees hold options/warrants on over 16 million shares of stock at 90 cents to $2.46.
Analyst slaps MiMedx with lack-luster “market perform” and notes looming uncertainties, issues.
Human placenta products peddler MiMedx (MDXG) is handing out company stock like candy to doctors who "evaluate technologies" or act as consultants, TheStreetSweeper has learned.

One doctor got tens of thousands of shares of common stock without paying one single dime. Another prominent doctor on the company's medical advisory board received options on 200,000 shares.

The company has doled out roughly 1.2 million shares of stock and options to its influential doctor friends - shares now worth more than $7 million - as its chief executive, Parker Petit, prepares to go on trial perhaps as early as next month for an alleged insider trading scheme.

Despite that, the company's stock price is screaming, shoving the market cap into the stratosphere. The company is now valued at about $740 million, much higher than the entire "skin substitution" market estimated at $500 million.

Paid to do what?

MiMedx uses doctors in speaking bureaus, consulting and research. But filings also say doctors educate others about "the efficacy and uses of our products." MiMedx's business turns mothers' placental membranes into "EpiFix" material used to cover injuries such as burns and diabetic foot sores, as well as "AmnioFix" for internal coverage uses such as spinal surgery and tennis elbow.


Simple, no one at this company has 1 ounce of ethics. They have paid for the vast majority of the business generated. Won't last much longer though...the investigations are well under way
 
This article was written on a blog called seeking alpha. People who write those blogs are paid by investors and companies with alterior motives...driving stock price up and down. That "blog" article carried no weight and was immediately shot down by legal counsel. More inaccuracies and rumors. What medical/pharma company doesn't have a speakers bureau? Laughable
 
This article was written on a blog called seeking alpha. People who write those blogs are paid by investors and companies with alterior motives...driving stock price up and down. That "blog" article carried no weight and was immediately shot down by legal counsel. More inaccuracies and rumors. What medical/pharma company doesn't have a speakers bureau? Laughable

shot down by whose legal counsel?
 
Simple, no one at this company has 1 ounce of ethics. They have paid for the vast majority of the business generated. Won't last much longer though...the investigations are well under way

Are you serious? This is the easiest product to sell on the market. 5 years shelf life, no freezers, no shipping issues, multiple sizes, no waste, multiple uses outside of wound care, numerous clinical papers being published in a wide array of peer reviewed journals(wound care-orthopaedics). People left Shire, Organo, Healthpoint, Amniox, Stability Bio to come here and sell the best product. It's not the other way around my man. The product sells itself and so does the job. Just another wannabe with no facts.
 
Haha. Yes I will. I was just making a comment on what I've heard. He had a reputation much like most of MiMedx. I see ABH 2.0 and we know how that ended. Isn't that what this board is about? If you don't like it, sorry.
 
You sir are pathetic. Get off our threads and cause trouble somewhere else. It's sad you can't sell anything so you resort to acting like you work here to try and make it seem like there are problems. Or you are someone shorting the stock. Either way- shut up and troll elsewhere.
 
BENSALEM, Pa.--(BUSINESS WIRE)--

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of purchasers of the securities of MiMedx Group, Inc. (“MiMedx” or the “Company”) (MDXG) between February 26, 2014 and December 31, 2014, inclusive (the “Class Period”). MiMedx designs, manufactures and markets tissue processing products and services in the United States. Long-term shareholders of MiMedx are encouraged to contact the firm for more information.

The Complaint alleges that defendants made false and misleading statements and failed to disclose material adverse facts about the Company’s business, operations and prospects. Specifically, defendants misrepresented and/or failed to disclose that the Company was in violation of federal regulations and, as a result, the Company’s statements were materially false and misleading at all relevant times.

On December 31, 2014, MiMedx announced the receipt of a civil subpoena from the Office of Inspector General of the Department of Health and Human Services, “in connection with a civil investigation into matters primarily related to the Company's sales and marketing activities.” That same day, the Company announced that it had filed a federal lawsuit against Organogenesis, Inc., alleging tortious interference of contract and interference with MiMedx’s dealings with the Veterans Administration; however, within a matter of weeks, MiMedx voluntarily dismissed the lawsuit.

If you purchased MiMedx shares between February 26, 2014 and December 31, 2014, you have until April 20, 2015, to move the Court to serve as lead plaintiff, if you meet certain legal requirements. To be a member of the Class you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the Class. If you are a long-term shareholder of MiMedx and would like to learn more about these claims, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, Toll Free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com, or visit our website at http://www.howardsmithlaw.com.
 
TROLLS!

Seriously- go look at some of the competitors and you will see the same stuff. This is nothing but a bunch of ambulance chasing lawyers. And the OIG stuff is total crap. Please, keep posting this stuff and help drive the stock a little lower so we can all buy more at a discount.

Idiots
 
TROLLS!

Seriously- go look at some of the competitors and you will see the same stuff. This is nothing but a bunch of ambulance chasing lawyers. And the OIG stuff is total crap. Please, keep posting this stuff and help drive the stock a little lower so we can all buy more at a discount.

Idiots

to the contrary, the stock prices keeps going up! :)
 
Simple, no one at this company has 1 ounce of ethics. They have paid for the vast majority of the business generated. Won't last much longer though...the investigations are well under way

Laine D - why are you on our site? Go buy a new empty suit and collect your Grafix checks with your bad policy team. WE ARE KICKING YOUR BUTTS. The real talent is here.
 
This article was written on a blog called seeking alpha. People who write those blogs are paid by investors and companies with alterior motives...driving stock price up and down. That "blog" article carried no weight and was immediately shot down by legal counsel. More inaccuracies and rumors. What medical/pharma company doesn't have a speakers bureau? Laughable

So you are saying that the company has ethics and doesn't have any compliance issues? No one here routinely pay off physicians or residents? No one give rare coins to VA doctors with rare coin collections? No one here have a CC on file at the best restaurant in town for customers to dine at their whim? No one here paying the residents to order their product on every patient? No one here tell other reps to stay out of my territory or my residents will sabotage your business?

Yeah, those are rumors right? No truth in any of that?
 


Write your reply...